Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 107

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 107
---
 Hayward, Ph.D., and Alison D. Silva) are non-independent
directors of the Company and four of its seven directors (Nicholas H. Hemmerly, Julie Kampf, Allison W. Brady, and Holger Weis) are “independent”
directors under Nasdaq listing standards. Therefore, the Board of Directors has determined that a majority of the members of our Board
of Directors are “independent”.

100

Committees
of the Board of Directors

Audit
Committee

We
have established an audit committee (“Audit Committee”), which consists of three independent directors: Holger Weis, Allison
W. Brady and Nicholas Hemmerly. Mr. Weis is the chair of the Audit Committee. Mr. Weis qualifies as an audit committee financial expert
under SEC rules and as a financially sophisticated audit committee member under the Nasdaq Capital Market rules. Our Audit Committee
operates under a written charter that is reviewed annually. A copy of the charter is posted on the Corporate Governance
section of our website, at www.jupiterneurosciences.com.

Our
Audit Committee is authorized to:

    ●
    approve
    and retain the independent auditors to conduct the annual audit of our financial statements;

    ●
    review
    the proposed scope and results of the audit;

    ●
    review
    and pre-approve audit and non-audit fees and services;

    ●
    review
    accounting and financial controls with the independent auditors and our financial and accounting staff;

    ●
    review
    and approve transactions between us and our directors, officers and affiliates;

    ●
    recognize
    and prevent prohibited non-audit services;

    ●
    establish
    procedures for complaints received by us regarding accounting matters; and

    ●
    oversee
    internal audit functions, if any.

Compensation
Committee

We
have established a compensation committee (“Compensation Committee”), which consists of three independent directors: Nicholas
H. Hemmerly, Julie Kampf and Allison Brady. Mr. Hemmerly is the chair of the Compensation Committee. Our Compensation Committee operates
under a written charter that is reviewed annually.7 A copy of the charter is posted on the Corporate Governance section
of our website, at www.jupiterneurosciences.com.

The
Compensation Committee is authorized to:

    ●
    review
    and determine the compensation arrangements for management;

    ●
    establish
    and review general compensation policies with the